369.33
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $369.33, with a volume of 1.42M.
It is up +0.89% in the last 24 hours and up +1.52% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$366.05
Open:
$369.65
24h Volume:
1.42M
Relative Volume:
0.78
Market Cap:
$141.37B
Revenue:
$25.12B
Net Income/Loss:
$3.25B
P/E Ratio:
43.98
EPS:
8.3984
Net Cash Flow:
$4.28B
1W Performance:
+2.29%
1M Performance:
+1.52%
6M Performance:
-3.30%
1Y Performance:
-4.12%
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
369.40 | 140.08B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
ABT
Abbott Laboratories
|
112.35 | 195.94B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
MDT
Medtronic Plc
|
96.57 | 127.55B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
76.24 | 110.83B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.23 | 44.03B | 6.07B | 1.06B | 799.60M | 1.8527 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Resumed | TD Cowen | Hold |
| Jan-06-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
W.G. Shaheen & Associates DBA Whitney & Co Has $9.64 Million Position in Stryker Corporation $SYK - MarketBeat
Skandinaviska Enskilda Banken AB publ Sells 3,223 Shares of Stryker Corporation $SYK - MarketBeat
Crestwood Advisors Group LLC Decreases Stake in Stryker Corporation $SYK - MarketBeat
Global Fibrin Sealant Market Size to Reach USD 3.57 Billion by 2035 with 8.37% CAGR – SNS Insider - GlobeNewswire Inc.
Are Wall Street analysts bullish on Stryker stock? - MSN
Public Sector Pension Investment Board Trims Stake in Stryker Corporation $SYK - MarketBeat
Stryker Launches T2 Alpha Humerus Nailing System for Fracture Care - cnhinews.com
ING Groep NV Makes New $18.55 Million Investment in Stryker Corporation $SYK - MarketBeat
Are Wall Street Analysts Bullish on Stryker Stock? - Barchart.com
Caprock Group LLC Purchases Shares of 10,070 Stryker Corporation $SYK - MarketBeat
Alps Advisors Inc. Decreases Stock Position in Stryker Corporation $SYK - MarketBeat
Decoding Stryker Corp (SYK): A Strategic SWOT Insight - GuruFocus
Stryker says US SEC drops foreign bribery probe - MLex
Is Stryker Corp Gaining or Losing Market Support? - Benzinga
Stryker launches T2 Alpha Humerus Nailing System, supporting surgical workflow and care for complex fractures - Finviz
Jensen Investment Management Inc. Decreases Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker (NYSE:SYK) Is Due To Pay A Dividend Of $0.88 - Yahoo Finance
Stryker Corp (SYK) Shares Up 3.33% on Feb 10 - GuruFocus
Stryker starts limited release of Mako RPS handheld knee robot - Yahoo Finance
Johnson Investment Counsel Inc. Boosts Stake in Stryker Corporation $SYK - MarketBeat
Applied Finance Capital Management LLC Sells 6,851 Shares of Stryker Corporation $SYK - MarketBeat
Stryker's (NYSE:SYK) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
Stryker introduces Mako Handheld Robotics with the limited market release of Mako RPS - Finviz
Stryker launches handheld robotic system for knee replacements - Investing.com
Stryker Corporation $SYK Shares Sold by Twin Capital Management Inc. - MarketBeat
Stryker Corp(SYK.US) Director Sells US$181.72 Million in Common Stock - 富途牛牛
Insider Selling: Stryker (NYSE:SYK) Director Sells 250,000 Shares of Stock - MarketBeat
Stryker Ronda E sells Stryker Corp (SYK) stock worth $181.7 million By Investing.com - Investing.com South Africa
Stryker Ronda E sells Stryker Corp (SYK) stock worth $181.7 million - Investing.com
Stryker Dividend Increase Signals Confidence In Earnings And Long Term Story - Yahoo Finance
J.W. Cole Advisors Inc. Trims Stock Position in Stryker Corporation $SYK - MarketBeat
Bear Alert: Is Stryker Corporation in a bullish channelBreakout Watch & Accurate Technical Buy Alerts - baoquankhu1.vn
Stryker Dividend Hike Highlights Shareholder Returns And Valuation Trade Offs - simplywall.st
Witnessing An Insider Decision, Spencer S Stiles Exercises Options Valued At $3.70M At Stryker - Benzinga
Stryker tops $25B in revenue and signals confidence in 2026 growth - Crain's Grand Rapids Business
Stryker declares quarterly dividend of $0.88 per share - Investing.com
Stryker declares an $0.88 per share quarterly dividend - The Globe and Mail
Jones Financial Companies Lllp Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker group president Pierce sells $175k in shares By Investing.com - Investing.com South Africa
Stryker group president Pierce sells $175k in shares - Investing.com
10 Best Health Care Stocks to Buy for 2026 - US News Money
Stryker Corporation $SYK Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Morgan Stanley Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $445 - 富途牛牛
Stryker Corporation (NYSE:SYK) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Atle Fund Management AB Has $8.42 Million Stake in Stryker Corporation $SYK - MarketBeat
Stryker (SYK) Earnings Call Highlights Growth and Resilience - TipRanks
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $387 to $465 - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Stryker Corporation (NYSE:SYK) Q4 2025 Earnings Call Transcript - Insider Monkey
Stryker raises annual profit forecast on strong sales for medical devices - Reuters
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):